학술논문

Sustained Remission with the Combination Biologic Doublet of Lenalidomide Plus Rituximab As Initial Treatment for Mantle Cell Lymphoma: A Multi-Center Phase II Study Report
Document Type
Journal
Source
BLOOD; DEC 6 2014, 124 21, 3p.
Subject
Language
English
ISSN
15280020